Alibaba Health Information Technology Limited Stock
Stocks
241
BMG0171K1018
Drug Retailers
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.470 HKD | +2.06% |
|
+5.47% | -31.29% |
| 29/06 | Chinese Biopharma Stocks Rally as Investors Favor Healthcare Over AI | DJ |
| 26/05 | Alibaba Health is Winning Battles but Losing the War |  |
| Market Cap | 48.51B 56.09B 7.15B 6.26B 5.77B 5.33B 10.12B 682B 10.29B 68.97B 27.08B 336B 26.86B 26.28B 1,156B | P/E 2026 |
34.3x | P/E 2027 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 37.46B 43.32B 5.53B 4.83B 4.46B 4.12B 7.81B 527B 7.94B 53.26B 20.92B 260B 20.75B 20.29B 892B | EV / Sales 2026 |
1.65x | EV / Sales 2027 * | 0.95x |
| Free-Float |
36.47% | Yield 2026 |
1.45% | Yield 2027 * | 0.96% |
| 1 day | +2.06% | ||
| 1 week | +5.47% | ||
| Current month | +12.66% | ||
| 1 month | +1.76% | ||
| 3 months | -25.22% | ||
| 6 months | -39.86% | ||
| Current year | -31.29% |
| 1 week | 3.21 |  | 3.57 |
| 1 month | 3.04 | | 3.6 |
| Current year | 3.04 | | 7.91 |
| 1 year | 3.04 | | 7.91 |
| 3 years | 2.59 | | 7.91 |
| 5 years | 2.59 | | 16.38 |
| 10 years | 2.59 | | 30.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 47 | 28/11/2023 |
Meng Yue Sheng
DFI | Director of Finance/CFO | 44 | 15/05/2026 |
Hua Zhang
HRO | Human Resources Officer | - | 01/02/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CHM | Chairman | 47 | 15/12/2025 |
Yi Fei Huang
BRD | Director/Board Member | 52 | 09/06/2019 |
Jiaojiao Huang
BRD | Director/Board Member | 44 | 15/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/06/25 | Other | Chief Executive Officer | 2,381,400 | 0.0148% | ||
| 13/06/25 | Other | Chief Financial Officer | 453,600 | 0.0028% | ||
| 18/06/24 | Other | Chief Executive Officer | 164,883 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.06% | +5.47% | -20.59% | -28.31% | 7.15B | |
| +2.19% | +3.32% | -12.44% | -27.01% | 15.2B | |
| -2.75% | +0.77% | -22.15% | -9.08% | 5.9B | |
| -0.15% | +0.75% | -17.78% | -34.07% | 3.6B | |
| +0.60% | -5.66% | -36.88% | -12.40% | 3.23B | |
| +0.11% | -2.13% | -28.68% | -48.55% | 3.18B | |
| 0.00% | +3.52% | +3.95% | -36.24% | 2.96B | |
| -0.24% | -2.48% | +100.78% | - | 2.59B | |
| -2.03% | -0.29% | -21.45% | -3.72% | 2.45B | |
| +0.34% | -0.06% | +1.40% | +41.13% | 1.71B | |
| Average | +0.01% | +0.15% | -5.39% | -17.58% | 4.8B | |
| Weighted average by Cap. | +0.59% | +1.48% | -10.81% | -22.69% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 35.16B 40.66B 5.19B 4.54B 4.18B 3.86B 7.33B 495B 7.46B 49.99B 19.63B 244B 19.47B 19.05B 838B | 38.6B 44.63B 5.69B 4.98B 4.59B 4.24B 8.05B 543B 8.18B 54.87B 21.55B 267B 21.37B 20.91B 919B |
| Net income | 2.21B 2.56B 326M 285M 263M 243M 461M 31.12B 469M 3.15B 1.24B 15.33B 1.23B 1.2B 52.71B | 2.09B 2.42B 309M 270M 249M 230M 437M 29.47B 444M 2.98B 1.17B 14.52B 1.16B 1.13B 49.9B |
| Net Debt | -11.05B -12.78B -1.63B -1.43B -1.31B -1.21B -2.3B -155B -2.34B -15.71B -6.17B -76.56B -6.12B -5.99B -263B | -12B -13.87B -1.77B -1.55B -1.43B -1.32B -2.5B -169B -2.54B -17.06B -6.7B -83.13B -6.64B -6.5B -286B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | HKD 3.470 | +2.06% | 131,278,962 |
| 09/07/26 | HKD 3.400 | -2.30% | 110,624,625 |
| 08/07/26 | HKD 3.480 | +6.75% | 220,825,935 |
| 07/07/26 | HKD 3.260 | -2.69% | 99,880,957 |
| 06/07/26 | HKD 3.350 | +1.82% | 135,548,920 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 241 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition